Related Experiment Video
Updated: Apr 6, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
Gynecologic cancer outcomes in the elderly poor: A population-based study
Kemi M Doll1,2,3, Ke Meng3, Ethan M Basch3
1Division of Gynecologic Oncology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina.
Older women with gynecologic cancers who are dually enrolled in Medicare and Medicaid face higher mortality risks. Disparities are most pronounced in early-stage uterine and vulvar/vaginal cancers, highlighting a need for targeted interventions.
Area of Science:
- Gynecologic Oncology
- Health Services Research
- Geriatric Medicine
Background:
- Dual enrollment in Medicare and Medicaid identifies an at-risk population among older adults (≥65 years).
- Outcomes for women with gynecologic cancers within this dual-enrollment group were previously unknown.
Purpose of the Study:
- To investigate the association between dual Medicare and Medicaid enrollment and outcomes in older women diagnosed with gynecologic cancers.
- To analyze all-cause mortality and disease stage at diagnosis based on enrollment status.
Main Methods:
- Population-based cohort study utilizing North Carolina cancer registry data (2003-2009).
- Linked enrollment data for Medicare and Medicaid.
- Multivariate analysis and survival curves to compare outcomes between dually enrolled and non-dually enrolled women.
Main Results:
- Dual enrollees (18%) experienced a 34% increase in all-cause mortality compared to non-dually enrolled individuals.
- Increased mortality was observed across all gynecologic cancer sites, with notable disparities in vulvar/vaginal cancers (aHR, 1.93).
- Dual enrollees with uterine cancer had higher odds of advanced-stage diagnosis (aOR, 1.38), with the most significant survival disparities seen in early-stage uterine and vulvar/vaginal cancers.
Conclusions:
- Dual Medicare and Medicaid enrollment is associated with significantly increased all-cause mortality in older women with gynecologic cancers.
- Early-stage uterine and vulvar/vaginal cancers show the most pronounced outcome disparities, suggesting potential benefit from targeted interventions.
- These findings underscore the need for tailored healthcare strategies to mitigate disparities in this vulnerable patient population.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
09:48An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Related Concept Videos
Cancer Survival Analysis
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism